Chardan Healthcare Acquisition Corp. (CHAC) financial statements (2021 and earlier)

Company profile

Business Address 17 STATE STREET, 16TH FLOOR
NEW YORK, NY 10004
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments820111
Cash and cash equivalents720111
Short-term investments10    
Restricted cash and investments0    
Receivables0    
Prepaid expense 0000
Other current assets2    
Total current assets:850111
Noncurrent Assets
Operating lease, right-of-use asset1   
Property, plant and equipment2    
Long-term investments and receivables 71717070
Long-term investments 71717070
Deposits noncurrent assets0    
Deferred income tax assets  0 
Other undisclosed noncurrent assets5    
Total noncurrent assets:871717070
TOTAL ASSETS:9271727171
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30000
Accounts payable3    
Taxes payable 0000
Debt0    
Other liabilities3    
Other undisclosed current liabilities 1000
Total current liabilities:61000
Noncurrent Liabilities
Long-term debt and lease obligation, including:1    
Other undisclosed long-term debt and lease obligation1    
Liabilities, other than long-term debt1 111
Deferred income tax liabilities   0
Due to related parties  111
Business combination, contingent consideration, liability1    
Total noncurrent liabilities:1 111
Total liabilities:81111
Temporary equity, carrying amount 65666665
Stockholders' equity
Stockholders' equity attributable to parent845555
Common stock00000
Additional paid in capital1275555
Accumulated other comprehensive loss(42)    
Retained earnings 0000
Total stockholders' equity:845555
TOTAL LIABILITIES AND EQUITY:9271727171

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
Revenues1    
Operating expenses(22)(1)(0)(0)(0)
Operating loss:(22)(1)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes10000
Income (loss) from continuing operations before income taxes:(21)(0)000
Income tax expense(2)(0)(0)(0)(0)
Income (loss) before gain (loss) on sale of properties:(23)(0)000
Other undisclosed net income2    
Net income (loss) attributable to parent:(21)(0)000
Other undisclosed net income available to common stockholders, basic41    
Net income (loss) available to common stockholders, diluted:20(0)000

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
Net income (loss):(21)(0)000
Comprehensive income (loss), net of tax, attributable to parent:(21)(0)000

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: